Cargando…

Development of experimental GBS vaccine for mucosal immunization

Streptococcus agalactiae, or group B streptococcus (GBS), is an important pathogen as it is the leading cause of neonatal deaths due to sepsis, meningitis or bacterial pneumonia. Although the development of an effective and safe GBS vaccine is on the agenda of many research labs, there is no GBS vac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupalova, T., Leontieva, G., Kramskaya, T., Grabovskaya, K., Bormotova, E., Korjevski, D., Suvorov, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935385/ https://www.ncbi.nlm.nih.gov/pubmed/29727446 http://dx.doi.org/10.1371/journal.pone.0196564

Ejemplares similares

Development of experimental pneumococcal vaccine for mucosal immunization
por: Gupalova, Tatiana, et al.
Publicado: (2019)

Combined immunization with attenuated live influenza vaccine and chimeric pneumococcal recombinant protein improves the outcome of virus-bacterial infection in mice
por: Kramskaya, T., et al.
Publicado: (2019)

Developing a Live Probiotic Vaccine Based on the Enterococcus faecium L3 Strain Expressing Influenza Neuraminidase
por: Desheva, Yulia, et al.
Publicado: (2021)

Construction of the Enterococcal Strain Expressing Immunogenic Fragment of SARS-Cov-2 Virus
por: Suvorov, Alexander, et al.
Publicado: (2022)

A Live Probiotic Vaccine Prototype Based on Conserved Influenza a Virus Antigens Protect Mice against Lethal Influenza Virus Infection
por: Mezhenskaya, Daria, et al.
Publicado: (2021)

Mucosal vaccine based on attenuated influenza virus and the group B Streptococcus recombinant peptides protected mice from influenza and S. pneumoniae infections
por: Desheva, Yulia, et al.
Publicado: (2019)

Correction: Development of experimental GBS vaccine for mucosal immunization
Publicado: (2018)

SARS-CoV-2 Spike Protein-Expressing Enterococcus for Oral Vaccination: Immunogenicity and Protection
por: Suvorov, Alexander, et al.
Publicado: (2023)

Prevention of Influenza A(H7N9) and Bacterial Infections in Mice Using Intranasal Immunization With Live Influenza Vaccine and the Group B Streptococcus Recombinant Polypeptides
por: Desheva, Yulia A, et al.
Publicado: (2017)

Evaluation in Mouse Model of Combined Virus-bacterial Vaccine Based on Attenuated Influenza A(H7N3) Virus and the Group B Streptococcus Recombinant Polypeptides
por: Desheva, Yulia A., et al.
Publicado: (2016)

Associated virus-bacterial vaccine based on seasonal LAIV and S. pneumoniae chimeric peptide provide protection against post-influenza pneumococcal infection in mouse model
por: Desheva, Yulia, et al.
Publicado: (2022)

Live Influenza Vaccine Provides Early Protection against Homologous and Heterologous Influenza and May Prevent Post-Influenza Pneumococcal Infections in Mice
por: Desheva, Yulia, et al.
Publicado: (2022)

Factors of early protective action of live influenza vaccine combined with recombinant bacterial polypeptides against homologous and heterologous influenza infection
por: Desheva, Yulia A., et al.
Publicado: (2019)

GBS-SBG - GBS Serotyping by Genome Sequencing
por: Tiruvayipati, Suma, et al.
Publicado: (2021)

NanoGBS: A Miniaturized Procedure for GBS Library Preparation
por: Torkamaneh, Davoud, et al.
Publicado: (2020)

A comparison of GenomEra® GBS PCR and GeneXpert ® GBS PCR assays with culture of GBS performed with and without broth pre-enrichment
por: Nielsen, S. Y., et al.
Publicado: (2020)

Post COVID-19 Vaccination GBS—Association or Causation?
por: Jain, Rajendra S., et al.
Publicado: (2022)

Evaluation of Xpert GBS assay and Xpert GBS LB assay for detection of Streptococcus agalactiae
por: Han, Meng-Yi, et al.
Publicado: (2021)

GBS and COVID-19: Untangling the Knots
por: Alcantara, Monica, et al.
Publicado: (2022)

Performance of BD MAX Group B Streptococcus (GBS) Assay without Enrichment for the Detection of GBS
por: Um, Sewhan, et al.
Publicado: (2022)

Autoprobiotics as an Approach for Restoration of Personalised Microbiota
por: Suvorov, Alexander, et al.
Publicado: (2018)

epiGBS2: Improvements and evaluation of highly multiplexed, epiGBS‐based reduced representation bisulfite sequencing
por: Gawehns, Fleur, et al.
Publicado: (2022)

Clinical Features of Post-Vaccination Guillain-Barré Syndrome (GBS) in Korea
por: Park, Yong-Shik, et al.
Publicado: (2017)

WHO GACVS reviews cases of GBS after COVID-19 vaccination
Publicado: (2021)

Janssen/Johnson & Johnson COVID-19 vaccine-related GBS in USA
Publicado: (2021)

Group B Streptococcus (GBS) colonization is dynamic over time, whilst GBS capsular polysaccharides-specific antibody remains stable
por: Haeusler, I L, et al.
Publicado: (2022)

Incidence of maternal GBS colonization and neonatal GBS disease among Very Low Birth Weight Polish neonates
por: Brzychczy-Wloch, Monika, et al.
Publicado: (2013)

Two case reports and a literature review of typical GBS and rare GBS variants associated with COVID-19
por: Orak, Sibğatullah Ali, et al.
Publicado: (2023)

A Novel Hexavalent Capsular Polysaccharide Conjugate Vaccine (GBS6) for the Prevention of Neonatal Group B Streptococcal Infections by Maternal Immunization
por: Buurman, Ed T, et al.
Publicado: (2019)

A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS)
por: Yamaguchi, Nobuko, et al.
Publicado: (2016)

The mucosal immune system: From dentistry to vaccine development
por: KIYONO, Hiroshi, et al.
Publicado: (2015)

The development of mucosal vaccines for both mucosal and systemic immune induction and the roles played by adjuvants
por: Kim, Sae-Hae, et al.
Publicado: (2017)

Cost-effectiveness of maternal GBS immunization in low-income sub-Saharan Africa
por: Russell, Louise B., et al.
Publicado: (2017)

Maternal Group B Streptococcal (GBS) Genital Tract Colonization at Term in Women who Have Asymptomatic GBS Bacteriuria
por: McKenna, David S., et al.
Publicado: (2003)

Comparison of the Panther Fusion and BD MAX Group B Streptococcus (GBS) Assays for Detection of GBS in Prenatal Screening Specimens
por: Berry, Gregory J., et al.
Publicado: (2019)

Seroepidemiology of maternally-derived antibody against Group B Streptococcus (GBS) in Mulago/Kawempe Hospitals Uganda - PROGRESS GBS
por: Kyohere, Mary, et al.
Publicado: (2020)

Editorial: Mucosal Vaccination: Strategies to Induce and Evaluate Mucosal Immunity
por: Kozlowski, Pamela A., et al.
Publicado: (2022)

Development of mucosal vaccine delivery: an overview on the mucosal vaccines and their adjuvants
por: Anggraeni, Rahmi, et al.
Publicado: (2022)

Dysfunction of Corticomotoneurons in Guillain-Barré Syndrome (GBS)?
por: Vucic, Steve
Publicado: (2009)

HIV positive patient with GBS-like syndrome
por: Shepherd, Samantha J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4d967te31q39pkm53fj5rqgg15